Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant based » significant barrier (Expand Search), significant burden (Expand Search), significant causal (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
Showing 701 - 720 results of 21,342 for search '(( ((significant based) OR (significant cause)) decrease ) OR ( significant decrease decrease ))', query time: 0.40s Refine Results
  1. 701
    Isotype control overlays.

    Isotype control overlays. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 702
    Original uncropped blot.

    Original uncropped blot. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 703
    Raw Data.

    Raw Data. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 704
    ALKG1202R –ABT199 interactions.

    ALKG1202R –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 705
    ALKC1156Y –ABT199 interactions.

    ALKC1156Y –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 706
    S1 Data -

    S1 Data - by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 707
    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.

    Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 708
    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.

    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 709
    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.

    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 710
    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures.

    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 711
    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.

    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 712
    Western blot analysis of drug combinations.

    Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 713
    ALKL1196M –ABT199 interactions.

    ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 714
    ALK<sup>wt</sup>–ABT199 interactions.

    ALK<sup>wt</sup>–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 715
    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression.

    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 716
    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.

    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 717
    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.

    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 718
    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment.

    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 719
    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein.

    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 720
    Volcano plot on differential expression.

    Volcano plot on differential expression. by Bingshuo Shi (21485387)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: